Ruchira papers break out1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula: - Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a quarterly sales and profit growth of 27% and 1365% respectively and TTM sales growth of 48% and TTM profit growth of 730%, NSE:RUCHIRA gave a high volume break out today from an 8-month long consolidation zone. Buy with a stop around rupees 92.
Other fundamental:
1. According to stock market experts, paper mills are least affected by recent global triggers like Ukraine-Russia war, soaring crude oil price and other commodity prices ascending to its multi-month highs. In fact, unlock theme has fueled demand for papers as schools and other educational institutions are reopening now. Recently pulp and waste paper prices in the international markets have gone up that may give margin benefits to the paper mills in upcoming quarters.
2. The Company has a manufacturing unit in Sirmaur, Himachal Pradesh. The current installed capacity stands at 400 TPD. This includes 250 tonnes per day of Kraft Paper and 150 tonnes per day of writing and printing paper. It also has a 8.1 MW captive power plant at its Kala Amb facility which helps source 100% of the power requirement of writing & printing paper from within.
3. The Co launched white copier paper and bleached kraft, which is used for the manufacture of carry bags with quality equivalent to the imported grade of bleached kraft in the market. The newly launched product constituted 12% of the revenues from writing and printing papers in FY21.
4. The Co is focusing on repayment of its long-term borrowings in FY22 and derisking of the balance sheet.
5. Stock is trading at 0.98 times its book value.
6. Promoter holding has increased by 1.36% over last quarter.
7. Debt to equity at 0.22 (less than 1 is good), Interest Coverage at 6.84 (greater than 3 is good), Current ratio at 1. 63% (greater than 1.5 is good).
8. Sector leader in terms of one month and six months' return.
Consolidation
BSOFT breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or daily RSI closing below 40
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Weekly tailing tops with high volume
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a consolidation since February 2022, NSE:BSOFT has given a break out today. It is a buy with a stop just below Rs.465.
Other fundamentals:
1. It is part of The CK Birla Group, Birlasoft, comprising over 10,000 plus professionals.
2. There has been an acceleration in Birlasoft’s participation in large deals, from the signing of multiple transformational projects, including a multi-services deal worth US$ 242 M TCV, with US-based healthcare major Invacare Inc. The Invacare deal is the largest deal in Birlasoft’s history.
3. In FY19, Birlasoft Ltd merged and amalgamated with KPIT Technologies Limited. The merger brought together with skill sets from both businesses. Birlasoft Ltd had strengths primarily in the non-ERP Digital businesses like CRM, BI & Data Analytics, and Application Development, while KPIT IT Services possessed core strengths on the Enterprise Software Solutions like Oracle, JD Edwards, SAP, Infor, etc and capabilities in Digital Transformation services. Birlasoft has created a niche in the mid-tier IT services companies following the merger with KPIT.
4. With successful integration with KPIT Technologies Limited in FY20, FY21 was the second year of operations, wherein the company witnessed stabilization and growth post restructuring. During FY21, the company sharpened its focus to build key business verticals through a micro-vertical strategy, made investments on major business partnerships to expand capabilities and increased focus on its top customers for effective client mining, thereby leading to improved deal wins and increased revenue per account. Going forward, with continued focus on such strategic initiatives are expected to yield sustained growth in operations and profitability for the company.
5. Company is almost debt free.
6. Company has been maintaining a healthy dividend payout of 24.62%.
7. Debtor days have improved from 79.00 to 53.20 days.
8. Debt to equity at 0.05 (less than 1 is good), Interest Coverage at 48.1 (greater than 3 is good), Current ratio at 3.60 (greater than 1.5 is good), FCF to CFO at 64.2%.
Southern Petrochem break out1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after quarter sales growth of 15%, quarter profit growth of 832%, and TTM sales growth of 15% and TTM profit growth of 318%, NSE:SPIC give a high volume break out on 21st March 2022 after a consolidation since July 2021. Today it came down to the previous resistance zone at Rs.68-69 and gave a bounce back. Buy with a stop just below Rs. 68.
Other fundamentals:
1. The company has reduced debt from 408 crores in March 2020 to 104 crores in September 2021.
2. The company has delivered good profit growth of 43.79% CAGR over last 5 years.
Suven Pharma high volume breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a consolidation since August 2021 NSE:SUVENPHAR gave a high volume break out today. It is a buy with a stop around Rs. 544.
Other fundamentals:
1. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women’s health. This segment makes up 78% of revenues. The company has a strong order book with new clients being consistently added. Most clients are the Big Pharma companies in Europe and the US. The company is looking to shift from Intermediate to API manufacturing and is in discussion with clients regarding this. The company has stated that it has the facilities for API manufacturing.
2. The Company is supplying intermediates – derived out of its CDMO competence – for two specialty chemical products (agrochemical) to large global conglomerates. In this segment, the company is currently working on two molecules with a new molecule to be developed next year.
3. The company has planned for a capex of Rs 600cr, a large part of which will be utilized in facility upgradation, technology enhancement and relocation spread over 3 years. This will be over and above the current ongoing capex of Rs 320cr spent over FY19-21. The capex would be mainly used for modernization of manufacturing facilities, relocation of R&D facilities and acquisition of new technologies. The company has already spent a Capex of Rs.94cr in 9MFY21 to expand its existing manufacturing facilities.
4. Suven Pharma is associated with more than 70 global companies. The company has an established market position in the CRAMS segment and is among the top five players in India who supply high-end intermediaries to innovators. Company is getting repeat business owing to long standing relationships with MNC companies. The industry has high entry barriers, needs deep technical expertise and is a sticky business.
5. Suven Pharma Inc. is a wholly owned subsidiary of SPL. It is a Special Purpose Vehicle created to invest in Rising Pharma Holdings Inc. Suven Pharma Inc. has 25 % holding in Rising Pharma Holdings Inc. Rising Pharma Holdings Inc. is a New Jersey, USA based pharmaceutical company focused on developing generic pharmaceuticals products in various therapeutic segments.
6. Company has reduced debt.
7. Debtor days have improved from 76.94 to 37.01 days.
8. Since June 2020 FII steak increased from 3.55 to 8.25.
9. Debt to equity at 0.10 (less than 1 is good), Interest Coverage at 104 (greater than 3 is good), Current ratio at 3.19 (greater than 1.5 is good).
HSCL breakout after 2 yrs consolidationHSCL is showing breakout signs after 1 yrs of consolidation with huge volumes. Post this breakout this can be good swing trade for short/medium term.
Levels are explained in charts
Disclaimer: This study is for educational purpose only & is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
IEX Ready for BreakoutIEX after good consolidation is now trying to give breakout post levels marked on the chart. Post this breakout this can be good swing trade for short term.
Levels are explained in charts
Disclaimer: This study is for educational purpose only & is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
TTK Healthcare break out 1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a quarter sales growth of 18%, quarter profit growth of 58%, TTM sales growth of 30% and TTM profit growth off 39%, NSE:TTKHLTCARE has given a high-volume breakout today after a consolidation since July 2021. One can buy with a stop at Rs. 798.
Other fundamentals: -
1. TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.
2. The company's pharmaceuticals business include products for both human and veterinary use :-
a. Ethical Products/ Pharma Division - The company's ethical pharma business deals in pharmaceutical formulations both herbal and allopathic, in various therapeutic segments and food supplements. It has a network of 1000+ sales team and a network of 3000+ distributors.
b. Animal Welfare Division - The company sells a wide range of animal pharma products under this division. Its portfolio includes feed supplements, fertility inducers, antibiotics, cocktail enzymes, etc. Its network is spread over 9,000 veterinarians across India.
3. The company's consumer products business comprises of marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good home range of scrubbers, air freshners, etc. The company's brand 'Woodward's Gripe Water' is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. Its distribution network includes 27 warehouses, 2,600+ distributors, 650+ frontline sales team and a reach to 4 lakh+ outlets across India.
4. The company is one of the largest manufacturers of extruded products (papad) in India which are B2B and export customers and are also marketed in selected markets in India. It sells its products under the brand name 'Fryums'.
5. Company is one of the key players in the Indian Condom Industry. It is involved in manufacture and marketing of male contraceptives and other allied products. It sells products under its own brand 'SKORE'.
6. The company's medical devices business is divided into 2 divisions :-
a. Orthopedics Division- The company's orthopedics division offers joint replacement portfolio which includes a variety of components, types and sizes. It has technical collaborations with various companies situated in USA, Germany, UK & Italy for the orthopedics business.
b. Heart Valve Division - The division manufactures and distributes heart valve prosthesis in India. It manufactures all 3 components for heart valve i.e. Frame, Disc & sewing ring. It has a manufacturing capacity of 20,000 heart valves p.a.
7. Presently, the company owns and operates 8 manufacturing facilities in India in Karnataka, Tamil Nadu, Puducherry, Kerala, and Rajasthan. It has adopted an outsourcing model for manufacturing most of its products, except for foods, medical and protective devices divisions.
8. Promoter Holding at 75% (greater than 45% is good)
9. Dividend Yield at 0.67% (consistent dividend payer since 2010)
10. Debt to equity at 0.02 (less than 1 is good), Interest Coverage at 17.3 (greater than 3 is good), Current ratio at 1.99% (greater than 1.5 is good), FCF to CFO at 59% (company won’t have to raise debt for expansion)
Delta Corp breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a quarter sales growth of 104%, quarter profit growth of 460%, TTM sales growth off 57% and TTM profit growth of 292%, NSE:DELTACORP gave a break out yesterday with high volumes after a consolidation since October 2021. Today the share price dropped below the previous support point of Rs.300 and bounced back. It is a buy with a stop just below Rs. 283, or it is a buy above Rs. 319 with a stop just below Rs. 297.
Other fundamentals:
1. Debt to equity at 0.00 (less than 1 is good), Interest Coverage at 20.6 (greater than 3 is good), Current ratio at 4.08 (greater than 1.5 is good).
2. Delta Corp Ltd is the largest gaming company in India and they are the only listed company in the casino gaming with 2000+ live gaming positions. They have managed to capture 55% of market share in the organized casino market and it has three major areas of business.
a. Casino's – Company operates casinos in Goa, Sikkim and Daman.
They operate 3 offshore casinos in Goa out of a total of 6 offshore casino licenses and also one land-based casino.
b. Online Gaming - Adda52.com currently offers online poker games. It currently holds number one position in India. The other website 'Adda52rummy.com' offers online games of Rummy.
c. Hospitality - Gaming and hospitality go hand in hand. Both these are mutually inclusive and reciprocating businesses, each driving the other.
3. The company is expanding its regional footprint by starting new casino center at Nepal upon receiving the gaming license in Feb 2020.
4. On Dec 12-2020 The company had received a license to establish a integrated resort consisting of hotels, convention centre, mutliplex cinema, electronic casino, retail area, water park and other facilities at Pernem, Goa.
5. The company owns 34% of Advani Hotels & Resorts Ltd which gives it the same stake in its Caravela Beach Resort situated at Varca Beach, Goa.
Saregama - An Investment OpportunitySaregama is under the long consolidation zone. Breakout can be observed in the stock above R2 (Mentioned in the Chart ).
Time to invest in a fundamentally good company.
Disclaimer- This is not a piece of investment advice. Please do consult your financial advisor before investing
swing trade idearunning above 50 and 200 DMA
big green candle after ascending consolidation exactly over 50 DMA
RSI giving conformation for buying side
Tremendous Breakout in Maithan Alloys !!!!Maithan alloys has given a breakout from a strong consolidation of 7 months,
also we can consider it as breakout a cup also because it hasn't achieved the target of
the cup it has formed till now, but could achieve in recent times .
Strong bull run in this stock is visible which was at halt for time being but now
resumed the uptrend again.
medium term weekly strong breakout fact- Now CIPLA is 4 digits stock
multi time frame breakout daily as well as weekly breakout
strong breakout with engulfing bullish candle
Question is ...
how we can trade this breakout?
we can enter with 20% quantity at this level & keep on tracking
whenever price come for retest breakout level and creating bullish sign we can enter remain quantity.
If this breakout fail to sustain then we will take small loss.
Maithan Alloys Breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Either sell on initial stop loss hit or when closes below weekly supertrend
After a Quarterly Sales and Profit growth of 107% and 441% and TTM Sales and Profit growth of 74% and 215%, NSE:MAITHANALL has given a breakout with high volumes after a long consolidation since Aug'21. It's a buy with a stoploss at Rs.1138.
Cipla Breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Either sell on initial stop loss hit or when closes below weekly supertrend
After a TTM Sales and Profit growth of 11.5% and 15% respectively and after receiving an approval from the Subject Expert Committee (“SEC”) of the Central Drugs Standard Control Organization (“CDSCO”) to conduct local trials on anti Covid-19 pill Paxlovid, NSE:CIPLA has given a breakout with higher than average volume. The breakout came after a long consolidation since Jun'21. It's a buy with a stop loss at Rs.979.
Consolidation and BreakoutSimple strategy to determine whether a market is in trend or not.
Breakout implies trending of market.
Consolidation shows market is range bound.
Scaling in 4 times the time frame will show the activity in details and Entry into the market can be done in smaller time frame.
This strategy is suitable for both Range traders as well as trend traders.
Possible entry exit will be shown in next link.
Nifty Today: “Take a Break” - 16 Feb’22
Nifty View: Flat close for the Nifty index in today's trading session - at a close of 17,317, the index lost just 43 points on a day on the basis. We see this as a sign of consolidation, especially after the recent wild price oscillation. It was good to notice that the Nifty and BankNifty indices reacted today from our anticipated resistance zones. Also, from now on towards tomorrow's trading session, it is very likely that the index will face selling pressure, and a break below today's low can infuse fresh selling. The underlying trend is still down, so trade cautiously, especially if you are long-biased.
Thank you for following my work and please feel free to share your thoughts and suggestions.
Trade Well. Trade Wise.